MicroSalt PLC - Result of AGM
MicroSalt Plc
("MicroSalt" or the "Company")
Result of AGM
MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, is pleased to announce that all resolutions proposed to shareholders at its Annual General Meeting were duly passed.
The total number of votes received in respect of all resolutions were as follows:
|
|
For |
Against |
Votes Withheld |
Total votes cast |
|||
|
Number of Votes |
% |
Number of Votes |
% |
||||
|
Ordinary Resolutions |
|||||||
|
1. Approval of Annual Report and Accounts |
34,766,508 |
99.90% |
33,980 |
0.10% |
54 |
34,800,488 |
|
|
2. To re-appointment Crowe U.K. LLP as Auditors |
34,760,383 |
99.90% |
35,073 |
0.10% |
5,086 |
34,795,456 |
|
|
3. To authorise Directors to set Auditors remuneration |
34,758,383 |
99.90% |
35,073 |
0.10% |
7,086 |
34,793,456 |
|
|
4. To re-elect |
34,336,743 |
98.69% |
456,713 |
1.31% |
7,086 |
34,793,456 |
|
|
5. To re-elect |
34,336,143 |
99.90% |
35,695 |
0.10% |
428,704 |
34,371,838 |
|
|
6. To re-elect |
34,336,143 |
98.69% |
457,313 |
1.31% |
7,086 |
34,793,456 |
|
|
7. To re-elect |
34,334,744 |
98.68% |
458,712 |
1.32% |
7,086 |
34,793,456 |
|
|
8. Authority to Allot Shares |
34,309,399 |
98.62% |
480,268 |
1.38% |
10,875 |
34,789,667 |
|
|
Special Resolution |
|||||||
|
9. Disapplication of pre-emption rights |
33,972,529 |
97.66% |
815,139 |
2.34% |
12,874 |
34,787,668 |
|
|
|
|
|
|
|
|
|
|
Notes:
1. Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.
2. Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".
4. The number of shares in issue on
5. The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at http://www.microsaltinc.com/.
For more information, please visit https://microsaltinc.com, follow on X @MicroSaltPLC or contact:
|
MicroSalt plc |
Via Gracechurch Group |
|
|
|
|
|
|
|
Zeus (Nominated adviser and broker) |
|
|
|
|
|
|
+44 (0)20 3829 5000 |
|
|
|
|
Gracechurch Group (Financial PR) |
+44 (0)20 4582 3500 |
|
|
|
About MicroSalt
MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.
MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.
Each year, cardiovascular disease costs the
Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.
The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.
MicroSalt is ideally positioned for scale and market leadership, with clear pathways into food manufacturing, consumer channels, and ultimately the broader £10+ billion global salt market. MicroSalt is more than a healthier alternative-it is a disruptive, category-defining solution poised to deliver significant commercial and societal impact.
For more information, please visit www.microsaltinc.com or follow on X @microSaltPLC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE